CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Endoscopic gastroplicationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00235677
NCT00235677Phase 3Completed
CompareCT.gov

A Blinded, Randomized, Sham-Controlled Trial of Endoscopic Gastroplication for the Treatment of Gastroesophageal Reflux Disease

UMC Utrecht·interventional·Posted Oct 10, 2005·Updated Oct 10, 2005

In Brief

A Phase 3 clinical trial evaluating Endoscopic gastroplication for Gastroesophageal Reflux. Completed, across 1 site.

Detailed Summary

Aim: To evaluate the therapeutic efficacy of a therapeutic procedure, involving endoscopic suturing, for gastroesophageal reflux disease (GERD) compared to a sham procedure. The hypotheses tested in this study were that active treatment would: 1) decrease the use of antisecretory medication, 2) decrease GERD symptoms, 3) improve quality of life, and 4) reduce esophageal acid exposure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGastroesophageal Reflux
CountriesNetherlands
Collaborators--

Timeline

Phase 3CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 10, 2005
Enrollment StartAug 1, 2003
Study CompletionAug 1, 2005
TodayJul 2, 2026
Posted 20.7 years ago

Interventions

Endoscopic gastroplicationprocedure